Annual prescriptions for drugs to treat attention-deficit/hyperactivity disorder (ADHD) increased 157% in Ontario from 2015 ...
Researchers say there's been a dramatic rise in the number of people going on medications to treat attention ...
ADHD (attention-deficit/hyperactivity disorder) is stunningly expensive to both the economy and to the people who live with ...
Medical Device Network on MSN
FDA greenlights Lumos Labs’ digital ADHD therapeutic
Lumos Labs’ LumosityRx is positioned for use alongside other ADHD treatment modalities such as medication and therapy.
News Medical on MSN
Sharp rise in ADHD stimulant prescriptions in Ontario,JAMA research finds
A new Ontario-based study has found a significant rise in prescriptions for stimulant medications used to treat ...
"With LumosityRx, we're taking the core science and technology behind Lumosity and applying it to help people with ADHD, where attention is crucial to everyday life," said Dr. Bob Schafer, ...
Study’s findings suggest there has been progress in treating the disorder, the researchers say, they also raise concerns ...
You deserved clarity years ago. You can have it now.SAN DIEGO, Dec. 6, 2025 /PRNewswire/ -- Foresight Psychology, based in ...
Lumos Labs has obtained a clearance from the FDA for its popular Lumosity brain training platform, greenlighting a version of ...
The study showed that neurodivergent individuals, particularly those with ADHD and autism, are overrepresented within prison ...
In some parts of the world, record numbers of people are being diagnosed with attention deficit hyperactivity disorder (ADHD) ...
Attention deficit hyperactivity disorder, or ADHD, is often linked to traits like forgetfulness and being easily distracted.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback